Broad Run Investment Management LLC bought a new stake in Danaher Corporation (NYSE:DHR - Free Report) in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 70,935 shares of the conglomerate's stock, valued at approximately $13,512,000. Danaher accounts for about 2.1% of Broad Run Investment Management LLC's investment portfolio, making the stock its 16th biggest holding.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Main Street Group LTD purchased a new position in shares of Danaher in the 1st quarter worth $25,000. N.E.W. Advisory Services LLC acquired a new stake in Danaher during the second quarter worth about $25,000. JPL Wealth Management LLC purchased a new position in shares of Danaher in the 3rd quarter worth about $25,000. WFA of San Diego LLC purchased a new stake in shares of Danaher during the 2nd quarter worth about $26,000. Finally, Hilton Head Capital Partners LLC acquired a new stake in Danaher during the 4th quarter worth approximately $27,000. Institutional investors and hedge funds own 79.05% of the company's stock.
Danaher Price Performance
Shares of DHR stock opened at $215.18 on Tuesday. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. The firm has a market cap of $151.27 billion, a P/E ratio of 38.22, a P/E/G ratio of 2.72 and a beta of 0.78. The firm has a fifty day moving average of $196.49 and a two-hundred day moving average of $192.39.
Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The business had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. During the same period in the prior year, the company posted $0.77 EPS. The business's revenue was up 5.5% compared to the same quarter last year. As a group, research analysts anticipate that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.
Analysts Set New Price Targets
DHR has been the topic of several research reports. Wolfe Research lowered shares of Danaher from an "outperform" rating to a "peer perform" rating in a report on Monday, June 1st. Guggenheim reduced their target price on shares of Danaher from $235.00 to $200.00 and set a "buy" rating on the stock in a report on Wednesday, July 22nd. Piper Sandler began coverage on Danaher in a report on Thursday, June 11th. They issued a "neutral" rating and a $200.00 price target for the company. Weiss Ratings raised Danaher from a "sell (d+)" rating to a "hold (c-)" rating in a research report on Wednesday, July 15th. Finally, Royal Bank Of Canada boosted their price objective on Danaher from $200.00 to $215.00 and gave the stock an "outperform" rating in a research note on Wednesday, July 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $228.91.
Get Our Latest Stock Analysis on Danaher
Danaher Profile
(
Free Report)
Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
